Biomedical subjects
Publications and source records attributed to J K Kammerer.
The complex task of managing the anemia caused by end-stage renal disease (ESRD) is more easily accomplished when the patient care team uses a protocol as a guide. The protocol outline presented in this article facilitates the management of patients with ESRD who are receiving Epoetin alfa. A case study is used to illustrate the clinical application of the protocol.
Epoetin alfa, widely used in treating the anemia caused by end-stage renal disease, provides several benefits to patients, including increased energy and an improved sense of well-being. Achieving these benefits depends on appropriate patient management. This article discusses how a multidisciplinary renal team can use continuous quality improvement principles to manage a suboptimal response to Epoetin alfa therapy caused by aluminum toxicity.
Explore the source record for details and available documents.